Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Emily Chan

6 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    VICCGI15122

    01/15/2016

    Research Use of Human Biospecimens from Colorectal Cancer Patients (Pilot Study)

    Treatment

    VICCPHI15100

    11/04/2016

    A First-in-Human Study of Repeat Dosing with REGN2810, a Monoclonal, Fully Human Antibody to Programmed Death-1 (PD-1), as Single Therapy and in Combination with Other Anti-Cancer Therapies, in Patients with Advanced Malignancies

    Treatment

    VICCGI1601

    10/31/2016

    A Phase I Trial of MEK Inhibitor Trametinib in Combination with Neoadjuvant 5-Fluorouracil Chemoradiation in the Treatment of Rectal Cancers

    Treatment

    VICCGI1667

    10/18/2016

    MM-151-06-12-04: A Phase 1 Study Combining MM-151 + nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer

    Treatment

    VICCGI1560

    10/10/2016

    Phase 2 Study of ADXS11-001 in Subjects with Persistent/Recurrent, Loco-Regional or Metastatic Squamous Cell Carcinoma of the Anorectal Canal

    Treatment

    VICCPHI1616

    06/08/2016

    A Phase 1 Open-Label Study of the Safety, Tolerability and Efficacy of KPT-9274, a Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies or Non-Hodgkin's Lymphoma


    Print this page for your doctor